The curse of the Scholarly Selective DR EDDIE CHAN VIDS REGISTRAR ROYAL MELBOURNE HOSPITAL
|
|
- Oswald Clarke
- 6 years ago
- Views:
Transcription
1 The curse of the Scholarly Selective DR EDDIE CHAN VIDS REGISTRAR ROYAL MELBOURNE HOSPITAL
2 INTRODUCTION 30M Medical student Working in an immunology laboratory PDI
3 Used with patient s express permission
4 Used with patient s express permission
5 Used with patient s express permission
6 Systemically well Afebrile No response to keflex No topical steroids used Used with patient s express permission
7 Journey to medical school Past Hx Chickenpox in childhood Hypertension Candesartan Dry skin diprosone ointment previously Antibodies to: VZV, Measles, mumps, rubella Hep B (SAb)
8
9 Oh, yeah.. Inoculated with live vaccinia on 3/2/2015 R deltoid site healed over completely 5 weeks post vaccination Minor regional lymphadenopathy
10
11 INVESTIGATIONS Normal FBE HIV negative CXR (9/5/15): normal 3x indeterminant Interferon-gamma release assays Negative Mantoux in past T-cell function measured in Feb research collaborators OX40 assay: normal T-cell response to Staph enterotoxin B and tetanus toxoid CD38 upregulated following vaccination to vaccinia
12 The search for the virus Orthopoxvirus PCR negative Lesion base Scab EM on hold Skin swab for M/C/S: leucocytes negative culture: negative
13 HISTOLOGY H&E x40
14
15 Vaccinia the smallpox vaccine Like variola, belongs in the Orthopoxvirus genus dsdna virus, 200kb Vax = replication competent strain Scarification bifurcated needle Formation of an erythematous papule within 3 to 5 days. It becomes a vesicle, then a pustule reaching a maximum size of 1 to 2 cm in 8 to 12 days, then scabs and separates by 14 to 21 days Spread by direct contact through broken or abrasions to skin or mucosal membranes
16 The vaccinia vaccine ACAM2000 Live, replication-competent vaccinia virus Derived from a plaque-purified clone of the same strain that was used to manufacture Dryvax vaccine Grown in African green monkey kidney (Vero) cells Administered in a single dose in the upper arm over the deltoid muscle by the percutaneous route (scarification) using 15 jabs of a stainless steel bifurcated needle cutaneous reaction: the development of a vesicle or pustule at the site of inoculation Risk of adverse effects Imvamune 3 rd generation vaccine Highly-attenuated live vaccine replication-restricted to avian cells following >570 passages in primary chicken embryo fibroblast cells Injected subcutaneously in 2 doses at 0 and 4 weeks for primary vaccinees Does not produce a visible cutaneous reaction following administration Safer Efficacy unproven CDC MMWR (2015) 64 (2):1-26
17 Who to vaccinate? Lab staff using live pox virus in research Australian Immunisation Handbook 9 th edition (2008) CDC recommendation Laboratory workers who directly handle cultures contaminated or infected with vaccinia, recombinant vaccinia, or other orthopoxviruses (such as monkeypox, cowpox, and others) Laboratory workers who directly handle animals contaminated or infected with vaccinia, recombinant vaccinia, or other orthopoxviruses Public health and health care response team members Military personnel
18 Don t [knowingly] vaccinate Impaired immunity HIV/AIDS Leukaemia/lymphoma General malignancy Agammaglobulinaemia High steroid doses Chemotherapy Pregnant/trying to get pregnant/breastfeeding Children <1 Vaccinated within last 30 days with a live vaccine Prev Hx of cardiac disease AMI/angina CCF/cardiomyopathy Valvular disease Eczema diagnosis (even if mild, or not presently active) Anyone living in a household with a member who has any of the conditions as listed above
19
20 Vaccinia related AE Lane; J Infect Dis (1970); 122(4):
21 Vaccinia related AE Poland; Vaccine (2005):
22 Generalised vaccinia Generalized vaccinia is a disseminated macropapular or vesicular rash appearing anywhere on the body The skin lesions of generalized vaccinia are thought to contain virus spread by the haematogenous route 5-9 days after smallpox vaccination May be accompanied by fever Can also appear as a regional form that is characterized by extensive vesiculation around the vaccination site or as an eruption localized to a single body region Usually self limiting Vellozzi; CID (2005); 41:689-97
23 Generalised vaccinia
24 Used with patient s express permission
25 Eczema vaccinatum Predilection for areas currently or previously affected by atopic dermatitis Disrupted skin in patients with atopic dermatitis permits viral implantation Local rash generalised, pox like eruption papular, vesicular, pustular, or erosive rash syndrome 5-19 days after exposure Lesions become necrotic + secondary infection Mortality rate 5-30% Children > adults Mx: VIG
26 Eczema vaccinatum
27 Used with patient s express permission
28 Eczema vaccinatum
29 Progressive vaccinia Due to continued vaccinia virus replication Enlargement of the primary inoculation site spreading to other parts of the body initial vaccination lesion continues to progress without apparent healing >15 days after smallpox vaccination Initial vesicles have no surrounding erythema & oedema Spread of virus in deep tissue necrosis & osteomyelitis Slower pace of development Results from defects in cell mediated immunity Mx: VIG Antivirals (cidofovir) Bray; CID (2003); 36: Vellozzi; CID (2005); 41:689-97
30 Progressive vaccinia
31 Bray; CID (2003); 36:766-74
32 Treatment options Vaccinia immunoglobulin prepared as a 20-fold concentrate of g-globulin from pooled plasma samples obtained from recently vaccinated military recruits A single inoculation of 0.6 1mL/kg of body weight was reported to produce prompt remission of generalized vaccinia and rapid improvement in many cases of eczema vaccinatum patients with progressive vaccinia often received multiple injections over the course of weeks to months Cidofovir highly protective against rapidly lethal orthopoxvirus infection in laboratory animals Immunomodulators Mice work: Th1 cytokines IL-2 and IFN-g stimulate orthopoxvirus clearance Methisazone Antiviral Thiosemi-carbazone derivatives were found to inhibit the replication of vaccinia virus Used in combo with VIg Ribavirin Used in 1 case Others (human fibroblast interferon, adeninie arabinoside, idoxuridine, whole blood) No effect Bray; CID (2003); 36:766-74
33 US marine vaccinated with vaccinia, then developed AML req induction chemo Diagnosed as progressive vaccinia (blood), complicated by superimposed bacterial infection Mx with: VIg o 341 vials used ST-246 (oral, topical) o 73 days oral, 68 days topical CMX-001 (prodrug of cidofovir) o 6x weekly doses Immune reconstitution important factor Lederman; JID (2012); 206:
34 Is this vaccinia 1. Temporal pattern is inconsistent 2. Patient is completely well 3. Lesion swabs PCR negative for orthopoxvirus 4. Histopathology doesn t show vaccinia
35 Of course it s discoid eczema! It can t be anything else! Its not related to the vaccine if that s what you re thinking!!!
36 Further Questions Why now, post vaccination? How common is discoid eczema post vaccination? Could it still be Vaccinia (ie. how sensitive is the PCR for picking up poxvirus in a human case?)
37 Uncle Jack, what are they? Picked up bubonic plague last weekend Don t they hurt? These, no they re just buboes!
38 Acknowledgements A/Prof Damon Eisen Dr Justin Denholm & Dr Irani Thevarajan
Smallpox Recognition and Vaccination
Smallpox Recognition and Vaccination Daniel R. Lucey, MD, MPH Georgetown University Medical and Law Centers Senior Scholar, O Neill Law Institute for Global Health Hong Kong Centre for Health Protection
More informationImportant Information About Vaccinia (Smallpox) Vaccine Please Read This Carefully
Important Information About Vaccinia (Smallpox) Vaccine Please Read This Carefully Introduction Vaccinia vaccine, previously known as smallpox vaccine, is highly effective in producing immunity to smallpox
More informationSMALLPOX QUESTIONS AND ANSWERS: The Disease and the Vaccine
SMALLPOX QUESTIONS AND ANSWERS: The Disease and the Vaccine In General What should I know about smallpox? Smallpox is an acute, contagious, and sometimes fatal disease caused by the variola virus (an orthopoxvirus),
More informationSmallpox Questions and Answers: The Disease and the Vaccine
Smallpox Questions and Answers: The Disease and the Vaccine IN GENERAL What should I know about smallpox? Smallpox is an acute, contagious, and sometimes fatal disease caused by the variola virus (an orthopoxvirus),
More informationMedication Guide ACAM2000 Smallpox (Vaccinia) Vaccine, Live
Medication Guide ACAM2000 Smallpox (Vaccinia) Vaccine, Live Please read this Medication Guide before you receive a vaccination with ACAM2000. This Guide does not take the place of talking to your healthcare
More informationTo provide guidance on prevention and control of illness caused by varicella-zoster virus (VZV).
Effective Date: 04/18 Replaces: 0 4 / 1 3 / 1 7 Page 1 of 4 POLICY: To provide guidance on prevention and control of illness caused by varicella-zoster virus (VZV). DEFINITIONS Two syndromes occur from
More informationFACT SHEET FOR ADDITIONAL INFORMATION CONTACT
FACT SHEET FOR ADDITIONAL INFORMATION CONTACT Caroline Calderone Baisley, MPH, RS Michael S. Long, MS Director of Health Director of Environmental Services Tel. 203-622-7836 Tel: 203-622-7838 SMALLPOX:
More informationISPUB.COM. A Practical Approach To Variola. C Gillespie INTRODUCTION DEFINING VARIOLA
ISPUB.COM The Internet Journal of Academic Physician Assistants Volume 4 Number 2 C Gillespie Citation C Gillespie.. The Internet Journal of Academic Physician Assistants. 2004 Volume 4 Number 2. Abstract
More informationPackage Insert. Dryvax, Smallpox Vaccine Dried, Calf Lymph Type, Wyeth Laboratories, Package Insert. Table of Contents
1 of 10 11/14/2002 1:36 AM Blood Therapeutics Vaccines Cellular & Gene Therapy Allergenics Tissue Devices Products Manufacturers Health Professionals Reading Room Meetings & Workshops Research About Us
More information142 Biomed Environ Sci, 2014; 27(2):
142 Biomed Environ Sci, 2014; 27(2): 142-146 Policy Forum Immune Control Strategies for Vaccinia Virus-related Laboratory-acquired Infections * WEI Qiang 1,#, JIANG Meng Nan 1, HAN Jun 2, and WANG Zi Jun
More informationOverview on smallpox vaccines. H. Meyer, Paul-Ehrlich-Institut
Overview on smallpox vaccines H. Meyer, Paul-Ehrlich-Institut 06.11.2013 1 Smallpox - features Ø Two principle clinical forms of smallpox can be differentiated, which are caused by different strains of
More informationI. Protocol for Approval to use Vaccinia Virus in Research
Vaccinia Virus SOP 2010 page 2 I. Protocol for Approval to use Vaccinia Virus in Research The Principal Investigator (PI) must submit the following to EHRS biohazreg@ehrs.upenn.edu: 1. A brief abstract
More informationTherapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections
Viruses 2010, 2, 2381-2403; doi:10.3390/v2102381 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections Yuhong
More informationThe University of Iowa Vaccinia Vaccination Information Form
The University of Iowa Vaccinia Vaccination Information Form I understand that due to my occupational exposure to vaccinia virus, I may be at risk of acquiring infection from vaccinia. I have been given
More informationSmallpox Vaccination in 2003: Key Information for Clinicians
INVITED ARTICLE CONFRONTING BIOLOGICAL WEAPONS Donald A. Henderson, Thomas V. Inglesby, and Tara O Toole, Section Editors Smallpox Vaccination in 2003: Key Information for Clinicians John Bartlett, 1,3
More informationCOMMUNICABLE DISEASES AND IMMUNISATION GUIDELINES
COMMUNICABLE DISEASES AND IMMUNISATION GUIDELINES The University recognises its responsibility to make available appropriate immunisation to employees potentially at risk of exposure to vaccine-preventable
More informationAcute, Generalized Vesicular or Pustular Rash Illness Testing Protocol in the United States
Acute, Generalized Vesicular or Pustular Rash Illness Testing Protocol in the United States Introduction This protocol has been developed to illustrate the types of laboratory testing to be undertaken
More informationMedical Management of Smallpox Patients and Vaccination Complications
Medical Management of Smallpox Patients and Vaccination Complications Public health officials should be immediately notified of any suspected smallpox patient. Currently, there is no proven treatment for
More informationWORLD HEALTH ORGANIZATION. Smallpox eradication: destruction of Variola virus stocks
WORLD HEALTH ORGANIZATION EXECUTIVE BOARD EB111/5 111th Session 23 December 2002 Provisional agenda item 5.3 Smallpox eradication: destruction of Variola virus stocks Report by the Secretariat 1. The WHO
More informationSmallpox Questions and Answers: The Disease and the Vaccine
Smallpox Questions and Answers: The Disease and the Vaccine IN GENERAL What should I know about smallpox? Smallpox is an acute, contagious, and sometimes fatal disease caused by the variola virus (an orthopoxvirus),
More informationBioterrorism: Medical and Public Health Perspectives
Bioterrorism: Medical and Public Health Perspectives Overview and Historical Perspective Marcelle Layton As weapons, biological agents have a number of advantages. There is the potential for wide dissemination
More informationSmallpox. Smallpox. Some persons infected with variola major virus have particularly severe illnesses. This suggests that there could be differences
Smallpox Smallpox is an acute infectious disease caused by the variola virus. Smallpox is believed to have emerged in human populations about 10,000 BCE A description of smallpox first appeared in a Chinese
More informationGeneralized Vaccinia, Progressive Vaccinia, and Eczema Vaccinatum Are Rare following Smallpox (Vaccinia) Vaccination: United States Surveillance, 2003
INVITED ARTICLE CONFRONTING BIOLOGICAL WEAPONS Donald A. Henderson, Thomas V. Inglesby, Jr., and Tara O Toole, Section Editors Generalized Vaccinia, Progressive Vaccinia, and Eczema Vaccinatum Are Rare
More informationINSTITUTIONAL BIOSAFETY COMMITTEE COMMUNICABLE DISEASES AND IMMUNISATION GUIDELINES
INSTITUTIONAL BIOSAFETY COMMITTEE COMMUNICABLE DISEASES AND IMMUNISATION GUIDELINES The University of South Australia recognises its responsibility to make available appropriate immunisation to employees
More informationVariola. Patricia Bolívar MS., CLS, PHM
Variola Patricia Bolívar MS., CLS, PHM Description and Significance Smallpox was one of the most notorious infections of mankind. It was declared eradicated by the World Health Assembly in 1979, 2 years
More informationVaccination to protect against shingles
Vaccination to protect against shingles - An update for registered healthcare practitioners The programme from September 2018 and contraindications and precautions Revised July 2018 NES and HPS accept
More informationInfectious Disease. Chloe Duke
Infectious Disease Chloe Duke Learning Objectives Essential - Causes, recognition and Treatment of: Meningitis Sepsis Purpura Important Cervical Adenopathy Tonsillitis and Pharyngitis Otitis Media Pneumonia
More informationVARICELLA. Infectious and Tropical Pediatric Division, Department of Child Health, Medical Faculty, University of Sumatera Utara
VARICELLA (Chicken pox) Infectious and Tropical Pediatric Division, Department of Child Health, Medical Faculty, University of Sumatera Utara Definition : Varicella is a common contagious disease caused
More informationTesting and Development of Orthopoxvirus Vaccines in the Era of the Animal Rule
Testing and Development of Orthopoxvirus Vaccines in the Era of the Animal Rule MRCE Making a Vaccine Against a Bioweapon Involves the FDA Animal Rule To allow appropriate studies in animals in certain
More informationDraft 2 Annex 1 Overview of Smallpox/Clinical Presentations/Medical Care ANNEX 1
ANNEX 1 Overview of Smallpox, Clinical Presentations, and Medical Care of Smallpox Patients A1-1 ANNEX 1 Overview of Smallpox, Clinical Presentations, and Medical Care of Smallpox Patients This annex is
More informationAtlantic Provinces Pediatric Hematology Oncology Network Réseau d oncologie et d hématologie pédiatrique des provinces de l Atlantique
Atlantic Provinces Pediatric Hematology Oncology Network Réseau d oncologie et d hématologie pédiatrique des provinces de l Atlantique Reviewed and approved by specialists at the IWK Health Centre, Halifax,
More informationSMALLPOX. Outline INTRODUCTION EPIDEMIOLOGY. Immediately report any suspected or confirmed cases of smallpox to: Also notify your:
SMALLPOX Outline Introduction Epidemiology Clinical Features Differential Diagnosis Laboratory Diagnosis Treatment and Prophylaxis Complications and Admission Criteria Infection Control Pearls and Pitfalls
More informationGene Vaccine Dr. Sina Soleimani
Gene Vaccine Dr. Sina Soleimani Human Viral Vaccines Quality Control Laboratory (HVVQC) Titles 1. A short Introduction of Vaccine History 2. First Lineage of Vaccines 3. Second Lineage of Vaccines 3. New
More informationVACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
VACCINATION DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. It is used to induce the
More information64848 1. Today's Date ( M M / D D / Y Y Y Y ) / / CHRONOLOGICAL RECORD OF MEDICAL CARE Smallpox Vaccination Initial Note Page 1 (2-Page Format) This page may be completed by potential vaccine recipient
More informationChickenpox Notification
Goolwa Campus: (08) 8555 7500 Victor Harbor Campus: (08) 8551 0900 Investigator College Chickenpox Notification Date for Distribution: 2018 Dear Parents/Caregivers There has been a case of chickenpox reported
More informationSmallpox is a very serious disease; it is contagious and sometimes fatal. Smallpox is cause by a germ called variola virus.
1. a. Smallpox - The Disease. What is smallpox? Smallpox is a very serious disease; it is contagious and sometimes fatal. Smallpox is cause by a germ called variola virus. The symptoms of smallpox begin
More informationSynopsis. Smallpox vaccine, LISTER strain, produced on chick embryo cells (VV LISTER/CEP) Live vaccinia virus (LISTER strain)
Synopsis Title of the trial: Coordinating Investigator: Trial centers: Publications: Trial period: Development phase: Primary objective: Take Evaluation and Safety of Smallpox Vaccine (LISTER Strain) in
More informationVACCINATION. C. Mhorag Hay
C. Mhorag Hay VACCINATION What you need to know: 1. The nature and function of passive and active immunization 2. The role of humoral and cellular immunity in vaccination 3. The types of vaccines currently
More informationViral Infections. 1. Prophylaxis management of patient exposed to Chickenpox:
This document covers: 1. Chickenpox post exposure prophylaxis 2. Chickenpox treatment in immunosuppressed/on treatment patients 3. Management of immunosuppressed exposed to Measles All children with suspected
More informationSmallpox: What Every Clinician Should Know
Printable Version of: Smallpox: What Every Clinician Should Know Contents: Welcome Message Practice Exercise Videos Additional Info: Self-Test Patient Education Materials References About This Training
More informationVaccines and other immunological antimicrobial therapy 1
Vaccines and other immunological antimicrobial therapy 1 Vaccines Vaccine: a biological preparation that provides active acquired immunity to a particular disease. Vaccine typically contains an agent that
More informationM I C R O B I O L O G Y
ninth edition TORTORA FUNKE CASE M I C R O B I O L O G Y a n i n t r o d u c t i o n 18 Practical Applications of Immunology PowerPoint Lecture Slide Presentation prepared by Christine L. Case Vaccine
More informationImmunizations for Health Care Workers
Immunizations for Health Care Workers Tanisha Taylor, MD, MPH Senior Medical Director Barnabas Health Corporate Care Tanisha Taylor MD, MPH Senior Medical Director Barnabas Health Corporate Care CDC Immunizations
More informationConcern for recurrence Stable virus especially in freeze dried form High infectivity in humans Vaccine supplies are limited No specific antiviral
poxviruses Poxviruses Infect humans, birds, mammals, and insects. DsDNA brick shaped, enveloped multiply in the cytoplasm, 100x200x300 nm. lack normal capsid instead, layers of lipoprotiens and fibrils
More informationCopyright regulations Warning
COMMONWEALTH OF AUSTRALIA Copyright regulations 1969 Warning This material has been reproduced and communicated to you by or on behalf of the University of Melbourne pursuant to part VB of the Copyright
More informationRecommendations for VZV management in. Dan Engelhard, Pierre Reusser, Rafael de la Camara, Hermann Einsele, Jan Styczynski, Kate Ward, Per Ljungman
Recommendations for VZV management in patients Cas cliniques with leukemia Dan Engelhard, Pierre Reusser, Rafael de la Camara, Hermann Einsele, Jan Styczynski, Kate Ward, Per Ljungman Introduction Acute
More informationImmunization. Historical point
Immunization Historical point In 1796 Edward Jenner s use of material from cowpox pustules to provide protection against smallpox. Louis Pasteur s 1885 rabies was the next to make an impact on human disease
More informationViruses: Select Agents and Emerging Pathogens. Patricia Bolívar MS., CLS, PHM
Viruses: Select Agents and Emerging Pathogens Patricia Bolívar MS., CLS, PHM Objectives Review Select Agent Viruses. Key features to recognize Smallpox virus Update on emerging Viruses of possible pandemic
More informationVaricella (Chickenpox) and Varicella Vaccines
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Varicella (Chickenpox) and Varicella Vaccines September 2018 Photographs and images included in this
More informationTrends in vaccinology
Trends in vaccinology Mathieu Peeters, MD Joint Conference of European Human Pharmacological Societies and Joint Conference of European Human Pharmacological Societies and 20th Anniversary of AGAH March
More informationSTANDING ORDERS FOR PRE- AND POST-EXPOSURE VACCINATION IN RESPONSE TO SMALLPOX OR MONKEYPOX: ACAM2000
STANDING ORDERS FOR PRE- AND POST-EXPOSURE VACCINATION IN RESPONSE TO SMALLPOX OR MONKEYPOX: ACAM2000 Purpose: To reduce the morbidity and mortality associated with smallpox (variola vim!) or monkeypox
More informationWHO Advisory Committee on Variola Virus Research
WHO/HSE/PED/CED/2013.1 WHO Advisory Committee on Variola Virus Research Report of the Fourteenth Meeting Geneva, Switzerland 16 17 October 2012 WHO Advisory Committee on Variola Virus Research Report
More informationShingles: What s New to Know
This material was prepared by the New England Quality Innovation Network-Quality Improvement Organization (NE QIN-QIO), the Medicare Quality Improvement Organization for New England, under contract with
More informationvirology MCQs 2- A virus commonly transmitted by use of contaminated surgical tools & needles produces a disease called serum hepatitis.
virology MCQs 1- A virus which causes AIDS is: a- Small pox virus. b- Coxsackie B virus. c- Mumps virus. d- Rubella virus. e- HIV-III virus. 2- A virus commonly transmitted by use of contaminated surgical
More informationRashes Not To Be Missed In Children
May 2016 Rashes Not To Be Missed In Children Dr Chan Yuin Chew Dermatologist Dermatology Associates Gleneagles Medical Centre Scope of presentation Focus on rashes May lead to significant morbidity if
More informationDecember 1, The Honorable Susan M. Collins Chairman Committee on Governmental Affairs United States Senate
United States General Accounting Office Washington, DC 20548 December 1, 2003 The Honorable Susan M. Collins Chairman Committee on Governmental Affairs United States Senate Subject: Smallpox Vaccination:
More informationCHILDHOOD VACCINATION
EPI (3) Age of Child How and Where is it given? CHILDHOOD VACCINATION Nicolette du Plessis Block 10 28/02/2012 10 weeks DTaP-IPV/Hib (2) Diphtheria, Tetanus, Acellular pertussis, Inactivated polio vaccine,
More informationVaccines. Vaccines ( continued 1) February 21, 2017 Department of Public Health Sciences
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 11 Vaccines Past, Present, Future Learning Objectives 1. Identify the various types of vaccines 2. Describe the role of vaccine in
More informationPrinciples of Vaccination
Immunology and Vaccine-Preventable Diseases Immunology is a complicated subject, and a detailed discussion of it is beyond the scope of this text. However, an understanding of the basic function of the
More informationVARICELLA. Dr Louise Cooley Royal Hobart Hospital
VARICELLA Dr Louise Cooley Royal Hobart Hospital Varicella Zoster Virus (VZV): The Basics Herpes virus Exclusively human infection Primary infection: varicella (chickenpox) Neurotropic, establishing latency
More informationArmed Services Blood Program Immunization List
Immunization List NOTICE: The Department of Defense (DoD) assumes no risk for the use of this information by non-dod personnel, blood programs, or individual medical institutions. The use of this information
More informationBCG Vaccine. For Intradermal Injection
BCG Vaccine For Intradermal Injection Name of the medicine BCG VACCINE, Bacillus Calmette and Guérin Description BCG Vaccine (Bacillus Calmette-Guérin) is a freeze-dried live bacterial vaccine prepared
More informationProcedure: Immunisation
Procedure: Immunisation Purpose To specify the minimum requirements and responsibilities for providing occupation related vaccinations and immunisation at the Australian National University (ANU) and to
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked
More informationProf Dr Najlaa Fawzi
1 Prof Dr Najlaa Fawzi is an acute highly infectious disease, characterized by vesicular rash, mild fever and mild constitutional symptoms. is a local manifestation of reactivation of latent varicella
More information9/10/2018. Principles of Vaccination. Immunity. Antigen. September 2018
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Principles of Vaccination September 2018 Chapter 1 September 2018 Photographs and images included in
More informationVACCINATION. Magdalena E. Sobieszczyk
Magdalena E. Sobieszczyk VACCINATION GOALS: 1. Understand passive and active immunization 2. Understand the role of humoral and cell-mediated immunity in vaccination 3. Review the types of vaccines currently
More informationA. Children born in 1942 B. Children born in 1982 C. Children born in 2000 D. Children born in 2010
Who do you think received the most immunologic components in vaccines? Development of which vaccine slowed after the invention of antibiotics? A. Children born in 1942 B. Children born in 1982 C. Children
More informationSMALLPOX AND BIOLOGICAL WARFARE STRUCTURE AND BIOLOGY OF POXVIRUSES PATHOGENESIS AND CLINICAL MANIFESTATIONS
Chapter 27 SMALLPOX DAVID J. MCCLAIN, M.D. * INTRODUCTION SMALLPOX AND BIOLOGICAL WARFARE STRUCTURE AND BIOLOGY OF POXVIRUSES PATHOGENESIS AND CLINICAL MANIFESTATIONS DIAGNOSIS MEDICAL MANAGEMENT Active
More informationThe Emerging Risks of Live Virus & Virus Vectored Vaccines:
The Emerging Risks of Live Virus & Virus Vectored Vaccines: A Referenced Report from the National Vaccine Information Center by Barbara Loe Fisher Co-founder & President Your Health. Your Family. Your
More informationIMMUNIZATION PROTOCOLS FOR PHARMACISTS. VARICELLA Live Virus Vaccine
IMMUNIZATION PROTOCOLS FOR PHARMACISTS VARICELLA Live Virus Vaccine I. ORDER: 1. Screen for contraindications and evidence of immunity (Section VII.K.) 2. Provide a current Vaccine Information Statement
More informationSection 10.5 Varicella
Section 10.5 Varicella Chickenpox Introduction Transmission Signs and Symptoms Complications Diagnosis Treatment Infection Prevention and Control Precautions for Residents with Chickenpox Additional considerations
More informationVaccination-Strategies
Vaccination-Strategies Active immunity produced by vaccine Immunity and immunologic memory similar to natural infection but without risk of disease. General Rule: The more similar a vaccine is to the disease-causing
More informationFor more information about how to cite these materials visit
Author(s): Sandro Cinti, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike 3.0 License: http://creativecommons.org/licenses/by-sa/3.0/
More informationPAEDIATRIC ACUTE CARE GUIDELINE. Impetigo. This document should be read in conjunction with this DISCLAIMER
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Impetigo Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should be read in conjunction
More information7. BCG Vaccination HSE/HPSC. Guidelines on the Prevention and Control of Tuberculosis in Ireland IUATLD criteria
7. BCG Vaccination The Bacillus Calmette-Guerin (BCG) vaccine was derived by in-vitro attenuation of the bovine tubercle bacillus between the years 1908 and 1918 in France. WHO encouraged widespread use
More informationEXANTHEMATOUS ILLNESS. IAP UG Teaching slides
EXANTHEMATOUS ILLNESS 1 DEFINITIONS Exanthema eruption of the skin Exanthema eruption of mucosae Macule flat nonpalpable lesion Papule small palpable lesion Nodule large palpable lesion Vesicle small fluid
More informationHealth Care Workers (HCWs) in Ireland should have 2 doses of MMR vaccine. Two of the cases in recent outbreaks in Ireland were HCWs.
This information should be read in conjunction with Immunisation Guidelines for Ireland available at http://bit.ly/niacguidelines Summary of Product Characteristics for MMR vaccines available at www.hpra.ie
More informationCAN YOU GET SHINGLES IF YOU'VE HAD THE CHICKENPOX VACCINE
12 May, 2018 CAN YOU GET SHINGLES IF YOU'VE HAD THE CHICKENPOX VACCINE Document Filetype: PDF 157.02 KB 0 CAN YOU GET SHINGLES IF YOU'VE HAD THE CHICKENPOX VACCINE The manufacturer of the vaccine say that
More informationLRI Children s Hospital. Management of chicken pox exposure in paediatrics
LRI Children s Hospital Management of chicken pox exposure in paediatrics Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team approval date: October 018 Version: V 3 Revision
More informationVaccine. Specific defenses Immunity. natural. acquired. Live vaccines. Killed Inactivated vaccines. Cellular fraction vaccines
Introduction Vaccine has been a importance medical breakthrough in preventing morbidity and mortality from infectious diseases worldwide. Vaccination has managed to eradicate the deadly and mutilating
More informationTDCJ OFFENDER IMMUNIZATION GUIDELINES
TDCJ OFFENDER IMMUNIZATION GUIDELINES B-14.07 Immunizations Attachment A VACCINE WHO GETS IT * WHEN THEY GET IT DOSE/ROUTE HPV Vaccine Females age 9 to 26 years if not previously vaccinated. On Intake
More information5 P&T Committee Formulary Action - March and May
TABLE OF CONTENTS Smallpox Update 1 Sliding Insulin 3 Medication Safety: Adult Critical Care Drip Sheet Heparin Dosing Rule P&T Committee Formulary Action - March and May 2003 Smallpox Update What is smallpox?
More informationAnatomy of an Exposure
Anatomy of an Exposure ABSA Conference Thomas Winters, MD, FACOEM, FACPM Occupational and Environmental Health Network Prologue to an Exposure Human error Underlying medical condition or disease Lack of
More informationBiological Warfare. International Bioweapons Programs. Bioterrorism: Medical and Public Health Perspectives. September 11, 2001
Bioterrorism: Medical and Public Health Perspectives Marcelle Layton, MD NYC Department of Health and Mental Hygiene Why There Was a Belief that Bioterrorism in the U.S. Would Never Happen Biologic weapons
More informationMonitoring Vaccines Introduction. Pia Caduff-Janosa MD May 2013
Monitoring Vaccines Introduction Pia Caduff-Janosa MD May 2013 Outline Historical background Are vaccines different from other medicinal products? Different vaccines different potential safety issues Immunization
More informationPerspectives on Improving International Vaccine Safety
Perspectives on Improving International Vaccine Safety Robert Ball, MD, MPH, ScM Director, Office of Biostatistics and Epidemiology Center for Biologics Evaluation and Research U.S. Food and Drug Administration
More informationMedical Bacteriology - Lecture 7. Spore- forming Gram Positive Rods. Bacillus
Medical Bacteriology - Lecture 7 Spore- forming Gram Positive Rods Bacillus 1 Bacillus Characteristics - Gram positive - Large rod. - Arranged in long chain - Spore forming - Aerobic or facultative anaerobic
More informationIMMUNIZATION IN CHILDREN WITH CANCER
SIOP PODC Supportive Care Education Presentation Date: 05 th September 2014 Recording Link at www.cure4kids.org: http://www.cure4kids.org/ums/home/conference_rooms/enter.php?room=p2xokm5imdj Email: ahmed.naqvi@sickkids.ca
More informationBiological Warfare. International Bioweapons Programs MID 42. Bioterrorism: Medical and Public Health Perspectives. September 11, 2001
Bioterrorism: Medical and Public Health Perspectives Marcelle Layton, MD NYC Department of Health and Mental Hygiene Biological Warfare 1943-1969 - US had active offensive program In 1972, U.S. and many
More informationMeasles and Measles Vaccine
Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More informationReviewers' comments: Reviewer #1 (Remarks to the Author):
Reviewers' comments: Reviewer #1 (Remarks to the Author): In the manuscript Rational Combination of CXCL11-Expressing Oncolytic Virus and PD-L1 Blockade Works Synergistically to Enhance Therapeutic Efficacy
More informationHistory and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8
History and aims of immunisation Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8 Objectives To examine the history of immunisation To explain the aim of immunisation To develop
More informationVaccination to protect against shingles - An update for registered healthcare practitioners
Vaccination to protect against shingles - An update for registered healthcare practitioners The programme from September 2016 and contraindications and precautions September 2016 NES and HPS accept no
More informationEdmunds: Introduction to Clinical Pharmacology, 8th Edition. 1. Which term refers to a medication containing a weakened or dead antigen?
This is completed: Test Bank for Introduction to Clinical Pharmacology 8th Edition by Edmunds http://testbankair.com/download/test-bank-for-introduction-to-clinical-pharmacology-8thedition-by-edmunds/
More informationPREVENTION OF INFECTIOUS DISEASES
PREVENTION OF INFECTIOUS DISEASES Loughlin AM & Strathdee SA. Vaccines: past, present and future. In Infectious Disease Epidemiology, 2 nd ed, Jones & Bartlett, 2007; p 374. Loughlin AM & Strathdee SA.
More informationTG4010. Public Information
TG4010 Public Information 11 May 2017 Public Information 11 May 2017 Page 2 /7 ABBREVIATIONS DNA Deoxyribonucleic acid GMO Genetically modified organism IL2 Interleukin-2 IM Intramuscular IT Intratumoral
More information